{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dose+Finding+Study&page=6", "query": { "condition": "Dose Finding Study", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 868, "total_pages": 87, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dose+Finding+Study&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dose+Finding+Study&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T02:56:51.876Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01962103", "title": "Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Neuroblastoma", "Rhabdomyosarcoma", "Ewing's Sarcoma", "Ewing's Tumor", "Sarcoma, Ewing's", "Sarcomas, Epitheliod", "Sarcoma, Soft Tissue", "Sarcoma, Spindle Cell", "Melanoma", "Malignant Melanoma", "Clinical Oncology", "Oncology, Medical", "Pediatrics, Osteosarcoma", "Osteogenic Sarcoma", "Osteosarcoma Tumor", "Sarcoma, Osteogenic", "Tumors", "Cancer", "Neoplasia", "Neoplasm", "Histiocytoma", "Fibrosarcoma", "Dermatofibrosarcoma" ], "interventions": [ { "name": "nab-paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "24 Years", "sex": "ALL", "summary": "6 Months to 24 Years" }, "enrollment_count": 107, "start_date": "2013-12-04", "completion_date": "2018-11-06", "has_results": true, "last_update_posted_date": "2019-12-27", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 2, "location_summary": "Phoenix, Arizona • New York, New York", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01962103" }, { "nct_id": "NCT00615446", "title": "A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "SU011248; Gemcitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2005-03", "completion_date": "2009-05", "has_results": false, "last_update_posted_date": "2010-04-30", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 3, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00615446" }, { "nct_id": "NCT01058018", "title": "Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atherosclerosis", "Coronary Artery Disease" ], "interventions": [ { "name": "RVX000222", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Resverlogix Corp", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 299, "start_date": "2009-12", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2023-04-03", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 1, "location_summary": "Tustin, California", "locations": [ { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01058018" }, { "nct_id": "NCT01743235", "title": "Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypoactive Sexual Desire Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Testosterone", "type": "DRUG" }, { "name": "Buspirone hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emotional Brain NY Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "21 Years to 70 Years · Female only" }, "enrollment_count": 207, "start_date": "2012-07", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2014-03-31", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 12, "location_summary": "San Diego, California • Bradenton, Florida • North Miami, Florida + 9 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "North Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01743235" }, { "nct_id": "NCT04667377", "title": "A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "BI 456906", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 387, "start_date": "2021-03-08", "completion_date": "2022-10-07", "has_results": true, "last_update_posted_date": "2023-11-02", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 10, "location_summary": "Walnut Creek, California • Louisville, Kentucky • Morehead City, North Carolina + 7 more", "locations": [ { "city": "Walnut Creek", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Morehead City", "state": "North Carolina" }, { "city": "Wilmington", "state": "North Carolina" }, { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04667377" }, { "nct_id": "NCT02477332", "title": "Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Spontaneous Urticaria" ], "interventions": [ { "name": "QGE031", "type": "BIOLOGICAL" }, { "name": "Omalizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 382, "start_date": "2015-07-15", "completion_date": "2017-06-12", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02477332" }, { "nct_id": "NCT00069277", "title": "Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "E7389", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2003-08", "completion_date": "2005-04", "has_results": true, "last_update_posted_date": "2012-04-11", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 3, "location_summary": "Los Angeles, California • Santa Monica, California • New Brunswick, New Jersey", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00069277" }, { "nct_id": "NCT00467844", "title": "Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cachexia" ], "interventions": [ { "name": "GTx-024", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GTx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 159, "start_date": "2007-05", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2014-07-11", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 50, "location_summary": "Anchorage, Alaska • Fayetteville, Arkansas • Corona, California + 41 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Corona", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00467844" }, { "nct_id": "NCT05387265", "title": "A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "CX-904", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CytomX Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2022-05-16", "completion_date": "2025-06-04", "has_results": false, "last_update_posted_date": "2025-07-14", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 5, "location_summary": "Denver, Colorado • Nashville, Tennessee • Houston, Texas + 2 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05387265" }, { "nct_id": "NCT06577935", "title": "A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postmenopausal Osteoporosis" ], "interventions": [ { "name": "AGA2118", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Angitia Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "80 Years", "sex": "FEMALE", "summary": "55 Years to 80 Years · Female only" }, "enrollment_count": 379, "start_date": "2024-10-31", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-10-22T02:56:51.876Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Gainesville, Georgia • Albuquerque, New Mexico + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gainesville", "state": "Georgia" }, { "city": "Albuquerque", "state": "New Mexico" }, { "city": "Duncansville", "state": "Pennsylvania" }, { "city": "Burien", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06577935" } ] }